| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$745 |
Shining Brighter RAS Infill Update
|
16 Jun 2025 8:49AM |
$0.580 |
$0.890 |
risen by
53.45%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
16 Jun 2025 8:49AM |
$1.690 |
$1.950 |
risen by
15.38%
|
|
| Toubani Resources Inc (TRE) ORDINARY FULLY PAID |
Materials |
$290 |
High Impact Depth Extension Drill Program Commences
|
16 Jun 2025 8:48AM |
$0.300 |
$0.455 |
risen by
51.67%
|
|
TRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Toubani Resources Inc. commences high-impact depth extension drilling at Kobada Gold Project in Mali.
- The program targets deeper extensions of main oxide and sulphide gold mineralization.
- Previous drilling demonstrated potential for resource expansion at depth.
- Kobada Gold Project has an extensive land package with multiple exploration targets.
- The project benefits from low stripping ratios and simple processing characteristics.
- Recent additions to the technical team strengthen project development capabilities.
- The drilling program is a key step toward expanding mineral resources and advancing project development.
- The initiative reinforces Kobada's status as a potential significant gold asset in West Africa.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qualitas Real Estate Income Fund (QRI) ORDINARY UNITS FULLY PAID |
Financials |
$746 |
Application for quotation of securities - QRI
|
16 Jun 2025 8:48AM |
$1.605 |
$1.580 |
fallen by
1.56%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$566 |
Update - Notification of buy-back - FPR
|
16 Jun 2025 8:48AM |
$2.990 |
$2.620 |
fallen by
12.37%
|
|
| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$496 |
Artrya Submits FDA Application - Coronary Plaque Module
|
16 Jun 2025 8:48AM |
$0.720 |
$3.140 |
risen by
336.11%
|
|
| Resolution Cap Global Prop Sec (Managed Fund) (RCAP) |
Financials |
$2,156 |
May 2025 Investment Update
|
16 Jun 2025 8:47AM |
$1.650 |
$1.830 |
risen by
10.91%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$75 |
Change of Director's Interest Notice - Tom Reardon
|
16 Jun 2025 8:47AM |
$0.640 |
$0.685 |
risen by
7.03%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$100 |
Update - Notification of buy-back - CAM
|
16 Jun 2025 8:46AM |
$0.710 |
$0.695 |
fallen by
2.11%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$181 |
Phase I Clinical Trial Dosing Update No 4
|
16 Jun 2025 8:46AM |
$0.200 |
$0.740 |
risen by
270%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Nyrada Inc provided an update on its Phase I clinical trial for its cholesterol-lowering drug candidate.
- The update is the fourth in a series of dosing announcements.
- The dose escalation protocol has been completed up to the planned dose levels.
- No serious adverse events or dose-limiting toxicities have been observed in any cohort.
- Interim safety and tolerability data indicate the candidate is well-tolerated at all tested doses.
- Pharmacokinetic data has been collected to inform future dosing regimens.
- Recruitment for subsequent cohorts is ongoing and further updates are expected.
- The successful progression of the trial supports further clinical development of NYR.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$257 |
Completion of Tolmer High Grade Silver Zone Drilling
|
16 Jun 2025 8:45AM |
$0.880 |
$1.075 |
risen by
22.16%
|
|
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,448 |
Aussie Broadband Board Announces New Non-Executive Director
|
16 Jun 2025 8:45AM |
$4.020 |
$4.950 |
risen by
23.13%
|
|
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$6,666 |
Venture Global CP2 LNG terminal progresses to construction
|
16 Jun 2025 8:44AM |
$13.470 |
$13.170 |
fallen by
2.23%
|
|
| Santos Limited (STO) ORDINARY FULLY PAID |
Energy |
$21,663 |
XRG Consortium nonbinding indicative proposal to acquire STO
|
16 Jun 2025 8:41AM |
$6.960 |
$6.670 |
fallen by
4.17%
|
|
STO - Price-sensitive ASX Announcement
Full Release
Key Points
- Santos Limited received a non-binding, indicative acquisition proposal from XRG Consortium.
- The proposed acquisition would be by scheme of arrangement for 100% of Santos' shares.
- The proposal offers a substantial premium over recent Santos share prices.
- Key conditions include satisfactory due diligence, financing, regulatory approvals, and Board recommendation.
- The proposal is non-binding and may not result in a transaction.
- Santos' Board is reviewing the proposal with its advisers.
- Shareholders are advised to take no action at this time.
- XRG Consortium’s members and their credentials are outlined.
- The announcement reiterates no certainty of a binding offer emerging.
- The assessment process and next steps are described for transparency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gibb River Diamonds Limited (GIB) ORDINARY FULLY PAID |
Materials |
$11 |
Edjudina Gold Project - Heritage Survey Completed over Neta
|
16 Jun 2025 8:41AM |
$0.033 |
$0.052 |
risen by
57.58%
|
|
GIB - Price-sensitive ASX Announcement
Full Release
Key Points
- Heritage survey at Neta Prospect, Edjudina Gold Project, has been completed.
- No sites of significance were identified during the survey.
- Survey conducted with Maduwongga Traditional Owners and Terra Rosa Consulting.
- RC drilling planned at multiple targets within Neta Prospect.
- Clearance from heritage survey allows drilling to proceed.
- Advances exploration strategy for the Edjudina Gold Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$7 |
Trading halt
|
16 Jun 2025 8:41AM |
$0.022 |
$0.007 |
fallen by
68.18%
|
|
X2M - Price-sensitive ASX Announcement
Full Release
Key Points
- X2M Connect Limited requested a trading halt on 5 June 2024.
- The trading halt is pending the release of an announcement by the company.
- The halt is to enable X2M to manage continuous disclosure obligations.
- The trading halt will remain until the earlier of normal trading on 7 June 2024 or the release of the announcement.
- X2M Connect Limited is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$664 |
Weekly NTA Estimate
|
16 Jun 2025 8:40AM |
$2.970 |
$2.900 |
fallen by
2.36%
|
|
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$38 |
AR9 Achieves Sale of NC Protect to US Department of Defense
|
16 Jun 2025 8:40AM |
$0.062 |
$0.078 |
risen by
25.81%
|
|
| EVE Health Group Limited (EVE) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Prescribing Agreement for ED and Dysmenorrhea Products
|
16 Jun 2025 8:38AM |
$0.035 |
$0.020 |
fallen by
42.86%
|
|
EVE - Price-sensitive ASX Announcement
Full Release
Key Points
- EVE Health Group Limited entered into a Prescribing Agreement for ED and dysmenorrhea products.
- Agreement sets out terms for healthcare professionals to prescribe EVE’s products.
- Eligibility requirements for patients and prescribers are specified.
- Details on the prescribing process and responsibilities of parties are included.
- Agreement emphasizes compliance with regulatory requirements.
- Provisions for monitoring, record-keeping, and regular review are present.
- Aims to ensure safe, effective, and responsible use of EVE’s medications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$181 |
Nyrada Investor Conference Call
|
16 Jun 2025 8:38AM |
$0.200 |
$0.740 |
risen by
270%
|
|
| IRIS Metals Limited (IR1) ORDINARY FULLY PAID |
Materials |
$39 |
IR1 confirms High-Grade Lithium at Edison as it advances dev
|
16 Jun 2025 8:36AM |
$0.135 |
$0.140 |
risen by
3.70%
|
|
IR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- IRIS Metals Limited (IR1) confirms high-grade lithium mineralization at the Edison Project in South Dakota.
- Significant assay results from recent drilling demonstrate high lithium oxide (Li2O) grades.
- Broad mineralized zones identified, supporting the potential for economically viable lithium deposits.
- Ongoing drilling, metallurgical testing, and permitting activities at Edison and Beecher projects.
- Strategic focus on contributing to the North American lithium supply chain.
- Company maintains active community engagement and environmental stewardship.
- IRIS Metals is well-funded to support continued exploration and development.
- Future plans include further drilling, resource definition, and advancing toward project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$82 |
Update - Notification of buy-back - M7T
|
16 Jun 2025 8:35AM |
$0.335 |
$0.350 |
risen by
4.48%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
Key Markets Update
|
16 Jun 2025 8:34AM |
$0.018 |
$0.015 |
fallen by
16.67%
|
|
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$701 |
Youanmi Dewatering Underway
|
16 Jun 2025 8:34AM |
$0.295 |
$0.505 |
risen by
71.19%
|
|
RXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Rox Resources Limited (RXL) has commenced dewatering at the Youanmi Gold Project.
- The dewatering is essential for enabling safe access to underground mine workings.
- This step is aligned with the company’s strategy to restart mining as outlined in the Youanmi Gold Project Feasibility Study.
- Rox has secured required funding, regulatory approvals, and infrastructure for the dewatering program.
- The program is scheduled to continue over several months, with progress updates anticipated.
- Completion of dewatering will allow for further development work and mining activities.
- The company emphasizes its commitment to environmental and regulatory compliance during operations.
- Rox Resources aims to deliver value to shareholders by advancing the Youanmi Gold Project toward production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$32 |
Update - Notification of buy-back - CDO
|
16 Jun 2025 8:33AM |
$1.695 |
$2.070 |
risen by
22.12%
|
|